Growth potential Elite Health Partners is transitioning toward public markets with an IPO planned by Q3 2024, signaling increasing scale and potential for larger contract manufacturing and 3PL collaborations, presenting opportunities to upsell integrated services to new institutional investors and larger brands.

Expanded capabilities The company combines contract manufacturing with technology-driven solutions via MIDAS Manufacturing and comprehensive 3PL fulfillment, creating cross-sell opportunities for clients seeking end-to-end, tech-enabled production and logistics optimization.

Strategic partnerships Recent Badger Fulfillment Group partnership indicates a push toward U.S.-based turnkey manufacturing and fulfillment, suggesting a market opening for similar collaborations with other U.S. clients seeking domestic, integrated supply chain solutions.

Market positioning Operating in liquid dietary supplements, personal care, and pet products within the CPG space, Elite Health Partners targets a broad wellness portfolio, presenting sales angles to consumer brands looking to scale compliant, quality-first manufacturing with tech insights.

Tech-forward sales MIDAS Manufacturing SaaS platform and real-time insights position Elite Health as a partner for brands prioritizing digital transparency and automation; pitch opportunities to brands seeking scalable, data-driven production and proactive process optimization.